Polycystic ovary syndrome (Pcos) in female-to-male (Ftm) transsexual persons

Calvar, Cecilia; Fernandez, Mirta; Duran, Yanina; Ballester, Gustavo Perez; Landini, Samanta

doi:10.1530/endoabs.41.ep682

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…35 Similarly, in a Spanish study reported in 2014, 35.4% of 77 trans men had PCOS. 13 In a few smaller studies 3,4,15,36 and a poster presentation, 14 the prevalence of PCOS in trans men has been reported to vary more widely, between 14.4% and 91.7%, depending on the size of the study group. In addition to that, some early histological studies on both human 37 and animal models 38,39 have demonstrated effects of androgens on ovarian follicular development, which may contribute to the higher prevalence of PCOS among trans men who are already on hormone treatment or with previous history of hormone treatment without any guidance by an endocrinology clinic.…”

Section: Discussionmentioning

confidence: 99%

“…[7][8][9][10][11] In the majority of clinical studies, the prevalence of PCOS among trans men has been reported as higher than among the cisgender population (individuals whose gender identities match their sex assigned at birth) which varies between 14.4% and 91.7%. 3,4,[12][13][14][15] In contrast to these former studies, a recent review by Liu et al has introduced no significantly different PCOS rates in trans men compared with a control group. 16 Unfortunately, no physiological mechanism explaining the association of GD and PCOS has been reported to date.…”

Section: Introductionmentioning

confidence: 95%

See 1 more Smart Citation

The Comparison of Gender Dysphoria, Body Image Satisfaction and Quality of Life Between Treatment-Naive Transgender Males With and Without Polycystic Ovary Syndrome

et al. 2022

View full text Add to dashboard Cite

The prevalence of polycystic ovary syndrome (PCOS) among trans men has been reported as higher than among the cisgender population, which varies between 14.4% and 58%. In this cross-sectional study, we aimed to evaluate the association of oligo-anovulation and/or features of hyperandrogenism with the scores on the Utrecht Gender Dysphoria Scale (UGDS), the Body Image Scale (BIS), and the Short Form-36 Health Survey (SF-36) in treatment-naive trans men with PCOS seeking help for gender transition. The study sample consisted of trans men who were diagnosed with gender dysphoria (GD) between December 2019 and November 2020. To assess body dissatisfaction and psychological functioning, the UGDS, BIS, and SF-36 were administered to all transgender individuals as part of the routine assessment procedure. A total of 49 treatment-naive trans men were included in our study; 38.8% (n = 19) of the participants were diagnosed with PCOS using the Rotterdam 2003 criteria. The scores of UGDS and BIS were significantly lower in the PCOS group compared with the non-PCOS group ( p < 0.001 and p = 0.003, respectively). Among the eight parameters within SF-36, general health, emotional role, and vitality scores were significantly higher in the PCOS group ( p = 0.031, p = 0.015, and p = 0.006, respectively). Our study is the first study that demonstrates significantly lower GD, higher body image satisfaction and quality of life in trans men with PCOS compared with those without PCOS. Our findings are promising for larger prospective cohort studies to develop a consensus on the management of PCOS in trans men.

show abstract